REG - JPMorgan Emerging MD - Closed Period Notification

JPMorgan Emerging Markets Dividend IncomeAnnouncement

02/02/2026 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260202:nRSB3790Ra&default-theme=true

RNS Number : 3790R  JPMorgan Emerging Mkts Div Inc PLC  02 February 2026

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN EMERGING MARKETS DIVIDEND INCOME PLC

(the 'Company')

 

Closed Period Notification

 

Legal Entity Identifier: 549300OPJXU72JMCYU09

Information disclosed in accordance with the Market Abuse Regulation

 

The Company announces that it is satisfied that all inside information which
the Directors and the Company may have in the period leading up to the
announcement of its half year results for the six months ended 31st January
2026 has previously been, and will continue to be, notified to the London
Stock Exchange via a regulatory information service. Therefore, the Company is
not prohibited from dealing in its own securities.

 

The mandatory closed period under the Market Abuse Regulation will commence on
24th February 2026 and will last until the half year results in respect of the
six months ended 31st January 2026 are published, which is expected on or
around 2nd April 2026.

 

If in the period leading up to the announcement of the half year results the
Directors of the Company come into the possession of any inside information,
this will be notified to the London Stock Exchange without delay and before
any such transactions are undertaken.

 

 

 

JPMorgan Funds Limited - Company Secretary

 

2nd February 2026

 

For further information, please contact:

 

Joel Clopon

JPMorgan Funds Limited

Telephone  0800 20 40 20 (or +44 1268 44 44 70)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBUGDDXXGDGLD



            Copyright 2019 Regulatory News Service, all rights reserved